(Q53918289)

English

Intracavernous alprostadil alfadex is more efficacious, better tolerated, and preferred over intraurethral alprostadil plus optional actis: a comparative, randomized, crossover, multicenter study.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10654905

Intracavernous alprostadil alfadex is more efficacious, better tolerated, and preferred over intraurethral alprostadil plus optional actis: a comparative, randomized, crossover, multicenter study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10654905

1 reference

based on heuristic

inferred from title

author name string

Shabsigh R

1

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10654905

Padma-Nathan H

2

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10654905

Gittleman M

3

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10654905

McMurray J

4

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10654905

Kaufman J

5

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10654905

Goldstein I

6

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10654905

language of work or name

0 references

publication date

1 January 2000

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10654905

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10654905

55

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10654905

1

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10654905

109-113

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10654905

NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900442-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Impotence: diagnosis and management of male erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900442-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900442-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind, placebo-controlled evaluation of the erectile response to transurethral alprostadil

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900442-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900442-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Transurethral alprostadil as therapy for patients who withdrew from or failed prior intracavernous injection therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900442-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind multicenter study comparing alprostadil alpha-cyclodextrin with moxisylyte chlorhydrate in patients with chronic erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900442-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracavernous alprostadil. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900442-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of transurethral alprostadil therapy in men with erectile dysfunction. MUSE Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900442-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Transurethral alprostadil with MUSE (medicated urethral system for erection) vs intracavernous alprostadil--a comparative study in 103 patients with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900442-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900442-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of erectile dysfunction with sildenafil.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900442-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900442-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0090-4295(99)00442-2

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10654905

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10654905

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53918289&oldid=1609837933"